Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 16,879 | 16,126 | 16,724 | 15,322 | 15,414 |
| Operating Income | -16,879 | -16,126 | -16,724 | -15,322 | -15,414 |
| Other Income | 375 | 380 | 226 | 162 | 139 |
| Pre-tax Income | -16,504 | -15,746 | -16,498 | -15,160 | -15,275 |
| Net Income Continuous | -16,504 | -15,746 | -16,498 | -15,141 | -15,275 |
| Net Income | $-16,504 | $-15,746 | $-16,498 | $-15,141 | $-15,275 |
| EPS Basic Total Ops | -0.51 | -0.49 | -0.61 | -0.67 | -0.68 |
| EPS Basic Continuous Ops | -0.51 | -0.49 | -0.61 | -0.67 | -0.68 |
| EPS Diluted Total Ops | -0.51 | -0.49 | -0.61 | -0.67 | -0.68 |
| EPS Diluted Continuous Ops | -0.51 | -0.49 | -0.61 | -0.67 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.49 | -0.61 | N/A | N/A |
| EBITDA(a) | $-16,465 | $-15,740 | $-16,338 | $-14,919 | $-15,023 |